agilon health (NYSE:AGL) Receives Sell Rating from Citigroup

Citigroup reaffirmed their sell rating on shares of agilon health (NYSE:AGL) in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have a $2.50 price objective on the stock, down from their prior price objective of $7.00.

A number of other brokerages also recently weighed in on AGL. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Royal Bank of Canada reissued an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Finally, Benchmark reissued a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, agilon health has a consensus rating of “Hold” and a consensus target price of $7.81.

agilon health Stock Performance

Shares of NYSE AGL opened at $2.52 on Tuesday. agilon health has a 52-week low of $2.49 and a 52-week high of $18.37. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.04 billion, a price-to-earnings ratio of -3.60 and a beta of 0.54. The stock’s fifty day simple moving average is $3.54 and its 200 day simple moving average is $5.11.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted ($0.04) earnings per share. agilon health’s revenue for the quarter was up 38.7% compared to the same quarter last year. As a group, sell-side analysts forecast that agilon health will post -0.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently made changes to their positions in the business. City State Bank bought a new position in shares of agilon health in the third quarter worth about $52,000. Inspire Investing LLC bought a new position in shares of agilon health in the third quarter worth about $414,000. SG Americas Securities LLC bought a new position in shares of agilon health in the third quarter worth about $92,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of agilon health in the second quarter worth about $1,849,000. Finally, Sanctuary Advisors LLC bought a new position in shares of agilon health in the second quarter worth about $197,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.